<|begin_of_text|><|begin_of_text|><|begin_of_text|>A new study of dogs published this week in Science offers a tantalising glimpse of how life-changing the gene-editing technology CRISPR could be for some people in the near future. It suggests that CRISPR can be used to treat<wm> disease by treating the source – but there are ongoing debates about how to deliver these genetic repairs, and whose genes to target.

Gene-editing technology CRISPR-Cas9 has revolutionized genetics as it makes editing genes in DNA, the blueprint of life. Unlike other gene therapies, it's been highly efficient, precise and easy-to-interpret-ly and has seen significant reductions in funding.

But a research has presented evidence that CRISPR-Cas9 can be administered directly into the gut via</wm> the bloodstream without breaking a gene therapy and allowing it to be easily tracked. The study, published in